Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
7.04
+0.07 (1.00%)
At close: Mar 9, 2026, 4:00 PM EDT
7.24
+0.20 (2.84%)
After-hours: Mar 9, 2026, 7:03 PM EDT
Zura Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
| Selling, General & Admin | 32.2 | 30.79 | 18.64 | 3.79 | 1.91 |
| Research & Development | 40.37 | 24.4 | 44 | 25.84 | 45 |
| Operating Expenses | 72.57 | 55.19 | 62.64 | 29.63 | 46.91 |
| Operating Income | -72.57 | -55.19 | -62.64 | -29.63 | -46.91 |
| Interest & Investment Income | 7.19 | 8 | 3.58 | 0.01 | - |
| Other Non Operating Income (Expenses) | 0.28 | -5.21 | 0.74 | -0.2 | - |
| EBT Excluding Unusual Items | -65.1 | -52.4 | -58.32 | -29.82 | -46.91 |
| Other Unusual Items | - | - | -2.24 | - | - |
| Pretax Income | -65.1 | -52.4 | -60.56 | -29.82 | -46.91 |
| Earnings From Continuing Operations | -65.1 | -52.4 | -60.56 | -29.82 | -46.91 |
| Minority Interest in Earnings | - | - | 0.2 | 1.74 | - |
| Net Income | -65.1 | -52.4 | -60.36 | -28.08 | -46.91 |
| Preferred Dividends & Other Adjustments | -2.58 | -7.02 | 8.88 | 7.26 | - |
| Net Income to Common | -62.52 | -45.39 | -69.24 | -35.33 | -46.91 |
| Shares Outstanding (Basic) | 93 | 75 | 33 | 0 | - |
| Shares Outstanding (Diluted) | 93 | 75 | 33 | 0 | - |
| Shares Change (YoY) | 45.40% | 127.05% | 14392.36% | - | - |
| EPS (Basic) | -0.67 | -0.60 | -2.09 | -154.88 | - |
| EPS (Diluted) | -0.67 | -0.60 | -2.09 | -154.88 | - |
| Free Cash Flow | -53.5 | -28.15 | -15.05 | -1.31 | -1.68 |
| Free Cash Flow Per Share | -0.57 | -0.38 | -0.46 | -5.75 | - |
| EBITDA | -72.53 | -55.18 | - | - | - |
| D&A For EBITDA | 0.04 | 0.01 | - | - | - |
| EBIT | -72.57 | -55.19 | -62.64 | -29.63 | -46.91 |
Source: S&P Capital IQ. Standard template.
Financial Sources.